[Form 4] CNO Financial Group, Inc. Insider Trading Activity

Rhea-AI Filing Summary

CNO Financial Group (CNO) disclosed an insider transaction by its Chief Investment Officer. On 11/10/2025, the executive exercised 71,400 employee stock options at an exercise price of $17.38 per share and then sold 48,665 shares at a $41.2414 weighted average price to cover the exercise price and required taxes. Following these transactions, the executive beneficially owned 671,542 shares directly. The options relate to grants that vested on 02/23/2018 and 02/23/2019 and expire on 02/23/2026. Sales occurred between $41.00 and $41.57 per share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Eric R.

(Last) (First) (Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL IN 46032

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Investment Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/10/2025		M		71,400	A	$17.38	720,207	D
Common Stock	11/10/2025		S		48,665(1)	D	$41.2414(2)	671,542	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$17.38	11/10/2025		M			71,400	(3)	02/23/2026	Common Stock	71,400	$0	0	D

Explanation of Responses:

1. Shares sold to cover the exercise price and the required tax withholding on the option exercise.

2. Reflects the weighted average sale price. Shares were sold at prices ranging from $41.00 per share to $41.57 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

3. One-half of the stock options vested on February 23, 2018, and one-half vested on February 23, 2019.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	11/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CNO’s CIO report on Form 4?

An option exercise of 71,400 shares at $17.38 and a sale of 48,665 shares with a weighted average price of $41.2414 on 11/10/2025.

Why were CNO shares sold by the reporting person?

The filing states the shares were sold to cover the exercise price and required tax withholding from the option exercise.

How many CNO shares does the insider own after the transactions?

The insider beneficially owns 671,542 shares directly following the reported transactions.

What was the sale price range for the CNO shares?

Sales occurred at prices ranging from $41.00 to $41.57 per share; the weighted average price was $41.2414.

When did the options vest and when do they expire?

One-half vested on 02/23/2018 and one-half on 02/23/2019; expiration is 02/23/2026.

What is the role of the reporting person at CNO (CNO)?

The reporting person is the company’s Chief Investment Officer.